Skip to main content
SpringerLink
Log in

Role of Brachytherapy in Treatment of Head and Neck Malignancy

  • Chapter
Book cover Squamous Cell Head and Neck Cancer

Part of the book series: Current Clinical Oncology ((CCO))

  • 857 Accesses

Abstract

Brachytherapy is an important armament available to the radiation oncologist treating cancers occurring in the head and neck region. It is all the more important in this era of organ preservation and improving quality of life (1,2). There are very few sites in the body where locoregional control is so vital to ultimate quality of life, organ function, and survival as in head and neck cancer. Brachytherapy permits dose intensification specifically to the tumor site while minimizing damage to the surrounding normal tissue and organs (3,4). This leads to an increased therapeutic ratio, while the patient also stands to gain functionally, psychologically, and cosmetically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Harrison LB, Zelefsky MJ, Pfister DG, et al. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 1997; 19:169–175.

    Article  PubMed  CAS  Google Scholar 

  2. Barrett WL, Gleich L, Wilson K, et al. Organ preservation with interstitial radiation for base of tongue cancer. Am J Clin Oncol 2002; 25:485–488.

    Article  PubMed  Google Scholar 

  3. Mazeron JJ, Noel G, Simon JM. Head and neck brachytherapy. Semin Radiat Oncol 2002; 12:95–108.

    Article  PubMed  Google Scholar 

  4. Levendag P, Nijdam W, Noever I, et al. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing? Int J Radiat Oncol Biol Phys 2004; 59:713–724.

    Article  PubMed  Google Scholar 

  5. Pigneux J, Richaud PM, Lagarge C. The placement of interstitial therapy using Ir-192 in the management of cancer of the lip. Cancer 1979; 43:1073–1077.

    Article  PubMed  CAS  Google Scholar 

  6. Lapeyre M, Bollet MA, Racodot S, et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 2004; 26:216–223.

    Article  PubMed  Google Scholar 

  7. Beitler JJ, Smith RV, Silver CE, et al. Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int. J Radiat Oncol Biol Phys 1998; 40:313–317.

    Article  PubMed  CAS  Google Scholar 

  8. Vikram B, Mishra S. Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck 1994; 16:155–157.

    Article  PubMed  CAS  Google Scholar 

  9. Looser KG, Shah JP, Strong EW. The significance of positive margins in surgically resected epidermoid carcinoma. Head Neck 1978; 1:107.

    Article  CAS  Google Scholar 

  10. Fu K, Ray JW, Chan EK et al. External and interstitial radiation therapy of carcinomas of the oral tongue: a review of 32 years of experience. Am J Roentgenol 1976; 127:107–115.

    Google Scholar 

  11. Brucer M. Brachytherapy. Am J Roentgenol 1968; 79:1080–1090.

    Google Scholar 

  12. Mazeron JJ, Gerbaulet A. The centenary of the discovery of radium. Cancer Radiother 1999; 3:19–29.

    PubMed  CAS  Google Scholar 

  13. Failla G. The development of filtered radon implants 1926; 16:507–525.

    CAS  Google Scholar 

  14. Wickham L, Degrais P. Radiumtherapie. Paris: Bailliere, 1909 (English ed: Radiumtherapy. London: Cassell, 1910; Radiumtherapy. New York: Funk and Wagnals, 1910.

    Google Scholar 

  15. Abbe R. Radium in surgery. JAMA 1906; 47:103.

    Google Scholar 

  16. Morton R. Treatment by roentgen and radium rays. Br. Med J 1904; 166:941–944.

    Article  Google Scholar 

  17. Paterson R, Parker HMA. A dosage system for gamma ray therapy. Br J Radiol 1934; 7:592–612.

    Google Scholar 

  18. Quimby EQ. Dosage tables for linear radium sources. Radiology 1944; 43:572.

    Google Scholar 

  19. Quimby EQ. The grouping of radium tubes in packs on plaques to produce the desired distribution of radiation. Am J Roentgenol 1932; 27:18.

    Google Scholar 

  20. Henschke U, Hilaris BS, Mahan GD. Afterloading in interstitial and intracavitary radiation therapy. Am J Roentgenol 1963; 90:386–395.

    CAS  Google Scholar 

  21. Pernot M, Luporsi E, Hoffstetter S, et al. Complications following definitive irradiation for cancers of the oral cavity and the oropharynx (in a series of 1134 patients). Int J Radiat Oncol Biol Phys 1997; 37:577–585.

    Article  PubMed  CAS  Google Scholar 

  22. Piro JD, Battle LW, Harrison LB. Conversion of complete dentures to a radiation shield prosthesis. J Prosthetic Dentistry 1991; 65:731–732.

    Article  CAS  Google Scholar 

  23. Clarke DH, Edmundson GK, Martinez A, et al. The utilization of I-125 seeds as a substitute for Ir-192 seeds in temporary interstitial implants: an overview and a description of the William Beaumont Hospital technique. Int J Radiat Oncol Biol Phys 1988; 15:1027–1033.

    PubMed  CAS  Google Scholar 

  24. Nath R. New directions in radionuclide sources for brachytherapy. Semin Radiat Oncol 1993; 3:278.

    Article  PubMed  Google Scholar 

  25. Nag S. Principles and Practice of Brachytherapy. Blackwell Futura, July 1997.

    Google Scholar 

  26. Joslin CAF, Flynn A, Hall EJ. Principles and Practice of Brachytherapy: Using Afterloading Systems. Hodder Arnold, June 2001.

    Google Scholar 

  27. Harrison LB, Zelefsky M, Armstrong JG, et al. Performance status after treatment for squamous cell cancer of the base of tongue—a comparison of primary radiation versus primary surgery. Int J Radiat Oncol Biol Phys 1994; 30:953–957.

    PubMed  CAS  Google Scholar 

  28. Pierquin B, Chassagne DJ, Chahbazian CM, et al. Brachytherapy. Warren H. Green, 1978.

    Google Scholar 

  29. Goffinet DR, Fee WE Jr, Wells J, et al. 192Ir pharyngoepiglottic fold interstitial implants. The key to successful treatment of base tongue carcinoma by radiation therapy. Cancer 1985; 55:941–948.

    Article  PubMed  CAS  Google Scholar 

  30. Levendag PC, Schmitz PIM, Jansen PP, et al. Fractionated high dose rate and pulsed dose rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys 1997; 38:497–506.

    Article  PubMed  CAS  Google Scholar 

  31. Strnad V, Lotter M, Grabenbauer G, et al. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery. Int J Radiat Oncol Biol Phys 2000; 46:27–30.

    Article  PubMed  CAS  Google Scholar 

  32. Erickson BA, Wilson JF. Nasopharyngeal brachytherapy. Am J Clin Oncol 1993; 16:424–443.

    Article  PubMed  CAS  Google Scholar 

  33. Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced naospharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16:1310–1317.

    PubMed  CAS  Google Scholar 

  34. Wang CC, Busse J, Gitterman M. A simple afterloading applicator for intracavitary irradiation of carcinoma of the nasopharynx. Radiology 1975; 115:737–738.

    PubMed  CAS  Google Scholar 

  35. Harrison LB, Nori D, Hilaris B, et al. Nasopharynx. in: The Interstitial Collaborative Working Group, ed. Interstitial Brachytherapy. New York: Raven, 1990:95–109.

    Google Scholar 

  36. Harrison LB, Weissberg JB. A technique for interstitial nasopharyngeal brachytherapy. Int J Radiat Oncol Biol Phys 1987; 13:451–453.

    PubMed  CAS  Google Scholar 

  37. Vikram B, Hilaris B. Transnasal permanent interstitial implantation of carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1984; 10:153–155.

    PubMed  CAS  Google Scholar 

  38. Harrison LB, Sessions RB, Fass DE, et al. Nasopharyngeal brachytherapy with access via a transpalatal flap. Am J Surg 1992; 164:173–175.

    Article  PubMed  CAS  Google Scholar 

  39. Syed AM, Puthawala AA, Damore SJ, et al. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years’ experience at Long Beach Memorial. Int J Radiat Oncol Biol Phys 2000; 47:1311–1321.

    Article  PubMed  CAS  Google Scholar 

  40. Pryzant RM, Wendt CD, Delclos L, et al. Re-treatment of nasopharyngeal carcinoma in 53 patients. Int J Radiat Oncol Biol Phys 1992; 22:941–947.

    PubMed  CAS  Google Scholar 

  41. Lee AW, Law SC, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: survival after local recurrence. Int J Radiat Oncol Biol Phys 1993; 26:773–782.

    PubMed  CAS  Google Scholar 

  42. Kwong DL, Wei WI, Cheng AC, et al. Long term results of radioactive gold grain implantation for treatment of persistent and recurrent nasopharyngeal carcinoma. Cancer 2001; 91:1105–1113.

    Article  PubMed  CAS  Google Scholar 

  43. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int J Radiat Oncol Biol Phys 1987; 13:953–956.

    PubMed  CAS  Google Scholar 

  44. Fu KK, Newman H, Phillips TL. Treatment of locally recurrent carcinoma of the nasopharynx. Radiology 1975; 117:425–431.

    PubMed  CAS  Google Scholar 

  45. Teo P, Leung SF, Choi P, et al. Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma. Br J Radiol 1994; 67:181–185.

    PubMed  CAS  Google Scholar 

  46. Choy D, Sham JST, Wei WI, et al. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993; 25:505–512.

    PubMed  CAS  Google Scholar 

  47. Syed AMN, Puthawala AA, Damore SJ, et al. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years experience at Long Beach Memorial. Int J Radiat Oncol Biol Phys 2000; 47:1311–1321.

    Article  PubMed  CAS  Google Scholar 

  48. Wang CC. Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost. Am J Clin Oncol 1998; 14:5–8.

    Article  CAS  Google Scholar 

  49. Levendag PC, Lagerwaard FJ, Noever I, et al. Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx. Int J Radiat Oncol Biol Phys 2002; 52:755–768.

    Article  PubMed  Google Scholar 

  50. Mazeron JJ, Richaud P:Lip cancer. Report of the 18th annual meeting of the European Curietherapy Group. J Eur Radiother 1984; 5:50–56.

    Google Scholar 

  51. Jorgensen K, Elbrond O, Anderson AP. Carcinoma of the lip: a series of 869 cases. Acta Radiol Ther Phys Biol 1973; 12:177–190.

    PubMed  CAS  Google Scholar 

  52. Mazeron JJ, Crook JM Benck V et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990; 19:1369–1376.

    PubMed  CAS  Google Scholar 

  53. Pernot M, Malissard L, Aletti P, et al. Iridium 192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol 1992; 23:223–228.

    Article  PubMed  CAS  Google Scholar 

  54. Mazeron JJ, Crook JM, Marinello G, et al. Prognostic factors of local outcome for T1, T2 carcinomas or oral tongue treated by iridium 192 implantation. Int J Radiat Oncol Biol Phys 1990; 19:281–285.

    PubMed  CAS  Google Scholar 

  55. Puthawala A, Syed A, Neblett D, et al. The role of afterloading iridium implant in the management of carcinoma of the tongue. Int J Radiat Oncol Biol Phys 1981; 7:407–412.

    PubMed  CAS  Google Scholar 

  56. Decroix Y, Ghossein NA. Experience of the Curie Institute in treatment of cancer of the mobile tongue: treatment policies and results. Cancer 1981; 47:496–502.

    Article  PubMed  CAS  Google Scholar 

  57. Inoue T, Inoue T, Teshima T, et al. Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys 1996; 36:1201–1204.

    Article  PubMed  CAS  Google Scholar 

  58. Leung TW, Wong VY, Kwan KH, et al. High dose brachytherapy for early stage oral tongue cancer. Head Neck 2002; 24:274–281.

    Article  PubMed  Google Scholar 

  59. Spiro RH, Strong EW. Epidermoid carcinoma of the mobile tongue. Treatment by partial glossectomy alone. Am J Surg 1971; 122:707–710.

    Article  PubMed  CAS  Google Scholar 

  60. Lapeyre M, Bollet MA, Racadot S, et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 2004; 26:216–223.

    Article  PubMed  Google Scholar 

  61. Lapeyre M, Hoffstetter S, Peiffert D, et al. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins. Int J Radiat Oncol Biol Phys 2000; 48:37–42.

    Article  PubMed  CAS  Google Scholar 

  62. Ange DW, Lindberg RD, Guillamondegui OM. Management of squamous cell carcinoma of the oral tongue and floor of mouth after excisional biopsy. Radiology 1975; 116:143–146.

    PubMed  CAS  Google Scholar 

  63. Hu KS, Sachdeva G, Harrison LB. Adjuvant interstitial iridium 192 brachytherapy for resected T1 and T2 cancers of the oral cavity with close or positive margins. Presented at the 6th International Head and Neck Conference, Washington DC, August, 2004.

    Google Scholar 

  64. Mendenhall WM, Parsons JT, Stringer SP, et al. Radiotherapy after excisional biopsy of carcinoma of the oral tongue/floor of mouth. Head Neck 1989; 11:129–131.

    Article  PubMed  CAS  Google Scholar 

  65. Chu A, Fletcher GH. Incidences and causes of failure to control by irradiation the primary lesion in squamous cell carcinomas of the anterior two thirds of the tongue and floor of mouth. Am J Roentgenol 1973; 117:502–508.

    CAS  Google Scholar 

  66. Benk V, Mazeron JJ, Grimard L, et al. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol 1990; 18:339–347.

    Article  PubMed  CAS  Google Scholar 

  67. Wendt CD, Peters LJ, Delclos L, et al. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys 1995; 18:1287–1298.

    Google Scholar 

  68. Mendenhall WM, Parsons JM, Stringer SP, et al. T2 oral tongue carcinoma treated with radiotherapy; analysis of local control and complications. Radiother Oncol 1989; 16:275–281.

    Article  PubMed  CAS  Google Scholar 

  69. Simon JM, Mazeron JJ, Pohar S, et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 1993; 26:19–25.

    Article  PubMed  CAS  Google Scholar 

  70. Mazeron JJ, Simon JM, Le Péchoux C, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinoma of mobile tongue and floor of mouth with interstitial iridium 192. Radiother Oncol 1991; 21:39–47.

    Article  PubMed  CAS  Google Scholar 

  71. Pernot M, Malissard L, Hoffstetter S, et al. The study of tumoral, radiobiological and general health factors that influence results and complications is a series of 448 oral oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys 1994; 29:673–679.

    PubMed  CAS  Google Scholar 

  72. Yamazaki H, Inoue T, Yoshida K, and et al. Brachytherapy for early oral tongue cancer: low dose rate to high dose rate. J Radiat Res 2003; 44:37–40.

    Article  PubMed  Google Scholar 

  73. Miura M, Takeda M, Sasaki T, et al. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer. Int J Radiat Oncol Biol Phys 1998; 41:763–770.

    Article  PubMed  CAS  Google Scholar 

  74. Pernot M, Luporsi E, Hoffsteitter S, et al. Complications following definitive irradiation of the oral cavity and the oropharynx (in a series of 1134 patients). Int J Radiat Oncol Biol 1997; 37:577–585.

    Article  CAS  Google Scholar 

  75. Pernot M, Hoffstetter S, Peiffert D, et al. Epidermoid carcinomas of the floor of mouth treated by exclusive irradiation: statistical study of a series of 207 cases. Radiother Oncol 1995; 35:177–185.

    Article  PubMed  CAS  Google Scholar 

  76. Mazeron JJ, Grimard L, Raynal M, et al. Iridium 192 for T1 and T2 epidermoid carcinomas of the floor of mouth. Int J Radiat Oncol Biol Phys 1990; 18:1299–1306.

    PubMed  CAS  Google Scholar 

  77. Matsumoto S, Takeda M, Shibuya H, et al. T1 and T2 squamous cell carcinomas of the floor of the mouth: results of brachytherapy mainly using 198Au grains. Int J Radiat Oncol Biol Phys 1996; 34:833–841.

    Article  PubMed  CAS  Google Scholar 

  78. Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 2001; 37:477–492.

    Article  PubMed  CAS  Google Scholar 

  79. Gerbaulet A, Pernot A. Cancer of the buccal mucosa. In: Proceedings of the 20th Annual Meeting of the European Curietherapy Group. J Eur Radiother 1985; 6:1–4.

    Google Scholar 

  80. Nair MK, Sankaranarayanan R, Padmanabhan TK. Evaluation of the role of radiotherapy in the management of carcinoma of the buccal mucosa. Cancer 1988; 61:1326–1331.

    Article  PubMed  CAS  Google Scholar 

  81. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54:8–29.

    PubMed  Google Scholar 

  82. Jesse RH Jr, Fletcher GH. Metastases in cervical lymph nodes from oropharyngeal cancer: treatment and results. Am J Roentgenol 1963; 90:990–996.

    CAS  Google Scholar 

  83. Pernot M, Malissard L, Hoffstetter S, et al. Influence of tumoral, radiobiological and general health factors on local control and survival of a series of 361 tumors of the velotonsillar area treated by exclusive irradiation (external beam + brachytherapy or brachytherapy alone). Int J Radiat Oncol Biol Phys 1994; 30:1021–1027.

    Google Scholar 

  84. Mazeron JJ, Belkacemi Y, Simon JM, et al. Place of iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas. Int J Radiat Oncol Biol Phys 1993; 27:251–257.

    PubMed  CAS  Google Scholar 

  85. Puthawala AA, Syed AM, Eads DL, et al. Limited external irradiation and interstitial 192 iridium implant in the treatment of squamous cell carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 1985; 11:1595–1602.

    PubMed  CAS  Google Scholar 

  86. Behar RA, Martin PJ, Fee WE Jr, et al. Iridium-192 interstitial implant and external beam radiation therapy in the management of squamous cell carcinomas of the tonsil and soft palate. Int J Radiat Oncol Biol Phys 1994; 28:221–227.

    PubMed  CAS  Google Scholar 

  87. Amornmarn R, Prempree T, Jaiwatana J, et al. Radiation management of carcinoma of the tonsillar region. Cancer 1984; 54:1293–1299.

    Article  PubMed  CAS  Google Scholar 

  88. Shugar MA, Nosal P, Gavron JP. Technique for routine screening for carcinoma of the base of tongue. J Am Dent Assoc 1982; 104:646–647.

    PubMed  CAS  Google Scholar 

  89. Crook J, Mazeron JJ, Marinello G, et al. Combined external irradiation and interstitial implantation for T1 and T2 epidermoid carcinomas of base of tongue: the Criteil experience (1971–1981). Int J Radiat Oncol Biol Phys 1988; 15:105–114.

    PubMed  CAS  Google Scholar 

  90. Simon JM, Mazeron JJ, Pohar S, et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 1993; 26:19–25.

    Article  PubMed  CAS  Google Scholar 

  91. Housset M, Baillet F, Dessard-Diana B, et al. A retrospective study of three treatment techniques for T1–T2 base of tongue lesions: surgery plus postoperative radiation, external radiation plus interstitial implant and external irradiation alone. Int J Radiat Oncol Biol Phys 1987; 13:511–516.

    PubMed  CAS  Google Scholar 

  92. Regueiro CA, Millan I, de la Torre A, et al. Influence of boost technique (external beam radiotherapy or brachytherapy) on the outcome of patients with carcinoma of the base of tongue. Acta Oncol 1995; 34:225–233.

    PubMed  CAS  Google Scholar 

  93. Harrison LB, Lee HJ, Pfister DG, et al. Long-term results of primary radiotherapy with/without neck dissection for squamous cell carcinoma of the base of tongue. Head Neck 1998; 20:668–673.

    Article  PubMed  CAS  Google Scholar 

  94. Horowitz EM, Frazier AJ, Martinez AA, et al. Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue with external irradiation and interstitial iodine 125 boost. Cancer 1996; 78:948–957.

    Article  Google Scholar 

  95. Puthawala AA, Syed AM, Eads DL, et al. Limited external beam and interstitial 192 iridium irradiation in the treatment of carcinoma of the base of tongue: a ten-year experience. Int J Radiat Oncol Biol Phys 1988; 14:839–848.

    PubMed  CAS  Google Scholar 

  96. Harrison LB, Zelefsky M, Pfister D, et al. Detailed quality of life assessment on long term survivors of primary radiation therapy for cancers of the base of tongue (abstract). Int J Radiat Oncol Biol Phys 1995; 32(suppl 1):180.

    Article  Google Scholar 

  97. Harrison LB, Zelefsky MJ, Sessions RB, et al. Base of tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome. Radiology 1992; 184:267–270.

    PubMed  CAS  Google Scholar 

  98. List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990; 66:564–569.

    Article  PubMed  CAS  Google Scholar 

  99. Cornes PG, Cox HJ, Rhys-Evans PR, et al. Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium-192 brachytherapy and surgical reconstruction. Br J Surg 1996; 83:1620–1622.

    Article  PubMed  CAS  Google Scholar 

  100. Choo R, Grimard L, Esche B, et al. Brachytherapy of neck metastases. J Otolaryngol 1993; 1:54–57.

    Google Scholar 

  101. Goffinet DR, Martinez A, Fee WE. I-125 vicryl suture implants as a surgical adjuvant in cancer of the head and neck. Int J Radiat Oncol Biol Phys 1985; 11:399–402.

    PubMed  CAS  Google Scholar 

  102. Goffinet DR. Brachytherapy for head and neck cancer. Semin Radiat Oncol 1993; 3:250–259.

    Article  PubMed  Google Scholar 

  103. Kumar PP, Good RR, Leibrock LG, et al. High activity Iodine 125 endocurietherapy for recurrent skull base tumors. Cancer 1988; 61:1518–1527.

    Article  PubMed  CAS  Google Scholar 

  104. Kumar PP, Good RR, Leibrock LG, et al. Tissue tolerance and tumor response following high activity iodine 125 endocurietherapy for skull base tumors. Endo Hyper Oncol1990; 6:223–230.

    Google Scholar 

  105. Gutin PH, Leibel SA, Hosobuchi Y, et al. Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources. Neurosurgery 1987; 20:938–945.

    Article  PubMed  CAS  Google Scholar 

  106. Mazeron JJ, Langlois D, Glaubiger D, et al. Salvage irradiation of oropharyngeal cancers using Iridium 192 wire implants: 5-year results of 70 cases. Int J Radiat Oncol Biol Phys 1987; 13:957–962.

    PubMed  CAS  Google Scholar 

  107. Syed AMN, Feder BH, George FW, et al. Iridium 192 afterloaded implant in the retreatment of head and neck cancers. Br J Radiol 1978; 51:814–820.

    Article  PubMed  CAS  Google Scholar 

  108. Peiffert D, Pernot M, Malissard L, et al. Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys 1994; 29:681–686.

    PubMed  CAS  Google Scholar 

  109. Lee DJ, Liberman FZ, Park RI, et al. Intra-operative I-125 seed implantation for extensive recurrent head and neck carcinomas. Radiology 1991; 178:879–882.

    PubMed  CAS  Google Scholar 

  110. Okuneiff P, Sundararaman S, Chen Y. Biology—IORT dose. In: Gunderson LL, Willet CG, Harrison LB, eds. Intraoperative Irradiation. Humana, Totowa, NJ: 1999:25–46.

    Google Scholar 

  111. Hu K, White C, Sachdeva G, et al. High Dose-Rate Intraoperative (HDR-IORT) iridium-192 radiation for head and neck cancer. In: American Brachytherapy Society New York, May 2003.

    Google Scholar 

  112. Nag S, Schuller D, Pak V, et al. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer. Radiother Oncol 1996; 41:125–130.

    Article  PubMed  CAS  Google Scholar 

  113. Garrett P, Pugh N, Ross D, et al. Intra-operative radiation therapy for advanced or recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 1987; 13:785–788.

    PubMed  CAS  Google Scholar 

  114. Rate WR, Garrett P, Hamaker R, et al. Intra-operative radiation therapy for recurrent head and neck cancer. Cancer 1991; 67:2738–2740.

    Article  PubMed  CAS  Google Scholar 

  115. Coleman CW, Roach M 3rd, Ling SM, et al. Adjuvant electron-beam IORT in high-risk head and neck cancer patients. Front Radiat Ther Oncol 1997; 31:105–111.

    PubMed  CAS  Google Scholar 

  116. Hu KS, Enker WE, Harrison LB. High-dose-rate intraoperative irradiation: current status and future directions. Semin Radiat Oncol 2002; 12:62–80.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Beth Israel Medical Center, New York, NY

    Ravi A. Shankar MD, Kenneth S. Hu MD & Louis B. Harrison MD

Authors
  1. Ravi A. Shankar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth S. Hu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Louis B. Harrison MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH

    David J. Adelstein MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Shankar, R.A., Hu, K.S., Harrison, L.B. (2005). Role of Brachytherapy in Treatment of Head and Neck Malignancy. In: Adelstein, D.J. (eds) Squamous Cell Head and Neck Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59259-938-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-938-7_7

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-473-9

  • Online ISBN: 978-1-59259-938-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation